Difference between revisions of "Canine Adenovirus 2"
Jump to navigation
Jump to search
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | {{ | + | {{unfinished}} |
− | |||
− | + | Also known as: '''''Infectious Canine Laryngotracheitis | |
− | |||
− | |||
− | + | ====Antigenicity==== | |
+ | *Some antigenicity shared between CAV 1 and 2, which lends to vaccination | ||
− | + | ====Pathogenesis==== | |
+ | *Causes '''necrosis''' of the '''respiratory tract''' with '''NO concurrent hepatitis''' | ||
+ | *Animals present with: | ||
+ | **Pyrexia | ||
+ | **Mild depression | ||
+ | **Nasal/ocular discharges | ||
+ | **Corneal opacity (not always) | ||
+ | **Dry, harsh, persistent cough | ||
− | == | + | ====Epidemiology==== |
+ | *Transfer is same as for [[Canine Adenovirus 1|CAV 1]] | ||
− | + | ====Diagnosis==== | |
+ | *Virus isolation from respiratory secretions | ||
− | == | + | ====Control==== |
+ | *Isolate coughing dogs and disinfect premises | ||
+ | *Vaccination: CAV 1 vaccine will cross protect | ||
− | |||
− | |||
− | + | [[Image:Adenovirus pneumonia.jpg|right|thumb|100px|<small><center>Adenovirus pneumonia (Image sourced from Bristol Biomed Image Archive with permission)</center></small>]] | |
− | + | *[[Adenoviridae|Adenoviridae]] | |
+ | *Usually mild [[Lungs Inflammatory - Pathology#Bronchointerstitial pneumonia|bronchointerstitial pneumonia]], necrosis of bronchiolar and alveolar epithelium, oedema, type II pneumocyte hyperplasia | ||
+ | *May cause necrotising [[Bronchi and Bronchioles Inflammatory - Pathology#Infectious causes of bronchitis or bronchiolitis|bronchiolitis]] in immune-deficient dogs ([[Paramyxoviridae#Canine Distemper Virus (CDV)|distemper]]) | ||
+ | *Can be associated with [[Canine Infectious Tracheobronchitis|kennel cough]] described above | ||
− | + | [[Category:Adenoviridae]][[Category:Dog Viruses]][[Category:Respiratory Pathology - Dog]] | |
− | + | [[Category:To_Do_-_Clinical/Viruses]] | |
− | + | [[Category:Respiratory_Viral_Infections]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | [[Category:Adenoviridae]] [[Category: |
Revision as of 16:27, 14 December 2010
This article is still under construction. |
Also known as: Infectious Canine Laryngotracheitis
Antigenicity
- Some antigenicity shared between CAV 1 and 2, which lends to vaccination
Pathogenesis
- Causes necrosis of the respiratory tract with NO concurrent hepatitis
- Animals present with:
- Pyrexia
- Mild depression
- Nasal/ocular discharges
- Corneal opacity (not always)
- Dry, harsh, persistent cough
Epidemiology
- Transfer is same as for CAV 1
Diagnosis
- Virus isolation from respiratory secretions
Control
- Isolate coughing dogs and disinfect premises
- Vaccination: CAV 1 vaccine will cross protect
- Adenoviridae
- Usually mild bronchointerstitial pneumonia, necrosis of bronchiolar and alveolar epithelium, oedema, type II pneumocyte hyperplasia
- May cause necrotising bronchiolitis in immune-deficient dogs (distemper)
- Can be associated with kennel cough described above